A study of 407 primary thyroid cancers showed PD-L1 expression in 6.1% of papillary thyroid carcinomas, 7.6% of follicular thyroid carcinomas, and 22.2% of anaplastic thyroid carcinomas at a threshold of 1% (87). This evidence concerns the gene CD274 and differentiated thyroid carcinoma.